Does 5-Hydroxytryptophan Cause Acute and Chronic Toxic Perturbations in Rats?

REFERENCES

• Adachi J., Gomez M., Smith C. C., Sternberg E. M. Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia–myalgia. Arch. Toxicol. 1995; 69: 266–270, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Adachi J., Mio T., Ueno Y., Naito T., Nishimura A., Fujiwara S., Sumino K., Tatsuno Y. Identification of four metabolites of 3-(phenylamino) alanine, a constituent of l-tryptophan products implicated in eosinophilia syndrome in rats. Arch. Toxicol. 1994; 68: 500–505, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bunag R. D. Validation in awake rats of a tail-cuff method measuring systolic pressure. J. Appl. Physiol. 1973; 34: 279–282, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Clauw D. J. Animal models of the eosinophilia-myalgia syndrome. J. Rheumatol. 1996; 23: 93–98, [CSA]
   PubMedGoogle Scholar
• Crofford L. J., Rader J. I., Dalakas M. C., Hill R. H., Jr., Page S. W., Needham L. L., Brady L. S., Heyes M. P., Wilder R. L., Gold P. W., Illa I., Smith C., Sternberg E. M. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J. Clin. Invest. 1990; 86: 1757–1763, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• DeSchryver-Kecskemeti K., Gramlich T. L., Crofford L. J., Rader J. I., Page S. W., Needham L. L., Hill R. H., Jr., Sternberg E. M. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with l-tryptophan implicated in human eosinophilia myalgia syndrome. Mod. Pathol 1991; 4: 354–357, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dunnett C. A multiple comparison procedure for comparing several treatments with control. J. Am. Statis. Assoc. 1955; 50: 1096–1121, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Hertzman P. A., Blevins W. L., Mayer J., Greenfield B., Ting M., Gleich G. J. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N. Eng. J. Med. 1990; 322: 869–873, [CSA]
   PubMed Web of Science ®Google Scholar
• Kilbourne E. M. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Epidemiol. Rev. 1992; 14: 16–36, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Klarskov K., Johnson K. L., Benson L. M., Cragun J. D., Gleich G. J., Wrona M., Jiang X. R., Dryhurst G., Naylor S. Structural characterization of a case-implicated contaminant, “Peak X” in commercial preparations of 5-hydroxytryptophan. J. Rheumatol. 2003; 30: 89–95, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lieberman S. Nutraceutical review: 5-hydroxytryptophan. Women's Health Alternative Medicine Report 2000; 2(1)4–6, [CSA]
   Google Scholar
• Love L. A., Rader J. I., Crofford L. F., Raybourne R. B., Principato M. A., Page S. W., Trucksess M. W., Smith M. J., Dugan E. M., Turner M. L., Zelazowski E., Zelazowski P., Sternberg E. M. Pathological and immunological effects of ingesting l-tryptophan and 1,1'-ethylidenebis in Lewis rats. J. Clin. Invest. 1993; 91: 804–811, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mayeno A. N., Gleich G. J. Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale. Trend Biotechnol. 1994; 12: 346–352, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Michelson D., Page S. W., Casey R., Trucksess M. W., Love L. A., Milstein S., Wilson C., Massaquoi S. G., Crofford L. J., Hallett M., Gold P. W., Sternberg E. M. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. J. Rheumatol. 1994; 21: 2261–2265, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Milburn D. S., Myers C. W. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome. DICP 1991; 25: 1259–1262, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Ogawa Y., Adachi J., Tatsuno Y. Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. Possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of l-tryptophan. Arch. Toxicol. 1993; 67: 290–293, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Philen R. M., Hill R. H., Jr., Flanders W. D., Caudill S. P., Needham L., Sewell L., Sampson E. J., Falk H., Kilbourne E. M. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia studies of Oregon, New York, and New Mexico. Am. J. Epidemiology 1993; 138: 154–159, [CSA]
   PubMed Web of Science ®Google Scholar
• Sato F., Hagiwara Y., Kawase Y. Subchronic toxicity of 3-phenylamino alanine, an impurity in l-tryptophan reported to be associated with eosinophilia-myalgia syndrome. Arch. Toxicol. 1995; 69: 444–449, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Silver R. M., Ludwicka A., Hampton M., Ohba T., Bingel S. A., Smith T., Harley R. A., Maize J., Heyes M. P. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan). J. Clin. Invest. 1994; 93: 1473–1480, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Williamson B. L., Benson L. M., Tomlinson A. J., Mayeno A N., Gleich G. J., Naylor S. On-line HPLC-tandem mass spectrometry analysis of contaminants of l-tryptophan associated with the onset of the eosinophilia-myalgia syndrome. Toxicol. Lett. 1997; 92: 139–148, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Williamson B. L., Tomlinson A. J., Hurth K. M., Posada de la Paz M., Gleich G. J., Naylor S. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia-myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome. Biomed. Chromotography 1998; 12: 255–261, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Yamaguchi Y., Tsunoda J., Suda T., Miura Y., Shioiri-Nakano K., Kasahara T. Effect of synthesized constituents in the l-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome. Biochem. Biophys. Res. Commun. 1991; 178: 1008–1013, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar